Terms ending in 2033
Every in-force patent on Antares Pharma, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,478,559 | Prefilled Syringe with Breakaway Force Feature In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 12,741,095 | Needle Assisted Injection Device Having Reduced Trigger Force In force · Medium confidence | Antares Pharma, Inc. | In force | Medium confidence | |
| US 10,821,072 | Needle Assisted Jet Injection Administration of Testosterone Compositions In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 11,844,804 | Administration of Testosterone Compositions In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 9,486,583 | Prefilled Syringe with Breakaway Force Feature In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 12,409,272 | Prefilled Syringe with Breakaway Force Feature In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 12,220,560 | Needle Assisted Injection Device Having Reduced Trigger Force In force · High confidence | Antares Pharma, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.